Phase 1 / 2 trial of Idasanutlin in combination with Ixazomib and dexamethasone in patients with 17p deleted, relapsed multiple myeloma

Sponsor
Mayo/MMRC

Protocol Number
MC1582 MMRC-061

To Learn More Call
201-510-0910